World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
63
Citations
13174
World Ranking
10285
National Ranking
279

Overview

Peter G. Parsons is affiliated with the QIMR Berghofer Medical Research Institute in Australia. Their research spans several fields, with primary focus areas in Biochemistry, Genetics and Molecular Biology, as well as Materials Science.

The subfields of study include:

  • Materials Chemistry
  • Molecular Biology
  • Biotechnology
  • Rehabilitation
  • Organic Chemistry

The scientist's main research topics cover a variety of specialized areas:

  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Bioactive Natural Diterpenoids Research
  • Wound Healing and Treatments
  • Marine Sponges and Natural Products
  • Cancer Research and Treatments
  • Photodynamic Therapy Research Studies

Recent scholarly contributions by Peter G. Parsons include:

  • Topical, immunomodulatory epoxy-tiglianes induce biofilm disruption and healing in acute and chronic skin wounds (2022), published in Science Translational Medicine
  • Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes (2021), published in Scientific Reports
  • Potent Antibacterial Prenylated Acetophenones from the Australian Endemic Plant Acronychia crassipetala (2020), published in Antibiotics
  • Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade (2024), published in Journal for ImmunoTherapy of Cancer
  • EBC-232 and 323: A Structural Conundrum Necessitating Unification of Five In Silico Prediction and Elucidation Methods (2020), published in Chemistry - A European Journal

Their frequent collaborators comprise:

  • Glen M. Boyle
  • Paul Reddell
  • Blake Ferguson
  • Jason K. Cullen
  • Natasa Broit

Peter G. Parsons has published repeatedly in venues that include:

  • The Cambridge Structural Database
  • Chemistry - A European Journal
  • Regular and Young Investigator Award Abstracts
  • Science Translational Medicine
  • Scientific Reports

Best Publications

  • Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.

    Adèle Green;Adèle Green;Gail Williams;Rachel Nèale;Veronica Hart

  • Histone Deacetylase Inhibitors Trigger a G2 Checkpoint in Normal Cells That Is Defective in Tumor Cells

    Ling Qiu;Andrew Burgess;David P. Fairlie;Helen Leonard

  • Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death.

    Steven M. Ogbourne;Andreas Suhrbier;Brad Jones;Sarah-Jane Cozzi

  • Ploidy as a prognostic determinant in surgically treated lung cancer

    P.V. Zimmerman;M.H. Bint;G.A.T. Hawson;P.G. Parsons

  • Characterization of the Melanoma miRNAome by Deep Sequencing

    Mitchell S. Stark;Sonika Tyagi;Derek J. Nancarrow;Glen M. Boyle

  • Microarray expression profiling in melanoma reveals a BRAF mutation signature.

    Sandra Pavey;Peter Johansson;Leisl Packer;Jennifer Taylor

  • What is transforming growth factor-beta (TGF-β)?

    David Chin;Glen M Boyle;Peter G Parsons;William B Coman

  • Melanocortin-1 Receptor Genotype is a Risk Factor for Basal and Squamous Cell Carcinoma

    Neil F Box;David L Duffy;Rachel E Irving;Anne Russell

  • Neutrophils Are a Key Component of the Antitumor Efficacy of Topical Chemotherapy with Ingenol-3-Angelate

    Jodie M. Challacombe;Andreas Suhrbier;Peter G. Parsons;Brad Jones

  • Novel markers for poor prognosis in head and neck cancer.

    David Chin;Glen M. Boyle;Rebecca M. Williams;Kaltin Ferguson

  • Multimodal Polymer Nanoparticles with Combined 19F Magnetic Resonance and Optical Detection for Tunable, Targeted, Multimodal Imaging in Vivo

    Barbara E. Rolfe;Idriss Blakey;Oliver Squires;Hui Peng

  • Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity.

    Andrew J. Burgess;Sandra Pavey;Robyn Warrener;Lisa-Jane K. Hunter

  • Validating Eaton's Hypothesis: Cubane as a Benzene Bioisostere

    Benjamin A Chalmers;Hui Xing;Sevan Houston;Charlotte Clark

  • CDKN2A/p16 is inactivated in most melanoma cell lines.

    Marina Castellano;Pamela M. Pollock;Marilyn K. Walters;Louise E. Sparrow

  • p53 expression and risk factors for cutaneous melanoma: A case‐control study

    David C. Whiteman;Peter G. Parsons;Adèle C. Green

  • Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate.

    L Qiu;M J Kelso;C Hansen;M L West

  • A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy

    K. A. O. Ellem;Michael G. E. O’Rourke;Gregory R. Johnson;Gordon Parry

  • Human Melanocytes and Keratinocytes Exposed to UVB or UVA In Vivo Show Comparable Levels of Thymine Dimers

    Antony R. Young;Christopher S. Potten;Osamu Nikaido;Peter G. Parsons

  • Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents.

    Kathy T Andrews;Anna Walduck;Mike J Kelso;David P Fairlie

  • Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma

    Neil F. Box;David L. Duffy;Rachel E. Irving;Anne Russell

Frequent Co-Authors

Glen M. Boyle
Glen M. Boyle QIMR Berghofer Medical Research Institute
Richard A. Sturm
Richard A. Sturm University of Queensland
Adèle C. Green
Adèle C. Green QIMR Berghofer Medical Research Institute
Andreas Suhrbier
Andreas Suhrbier QIMR Berghofer Medical Research Institute
Paul V. Bernhardt
Paul V. Bernhardt University of Queensland
Denis J. Moss
Denis J. Moss QIMR Berghofer Medical Research Institute
David P. Fairlie
David P. Fairlie University of Queensland
Peter Conrad Healy
Peter Conrad Healy Griffith University
Nicholas K. Hayward
Nicholas K. Hayward QIMR Berghofer Medical Research Institute
Brian Gabrielli
Brian Gabrielli University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens a range of online study options and career pathways. Many students start healthcare careers with online medical assisting classes, which offer quick entry into clinical roles while supporting your education with financial aid opportunities.

For those looking to advance from medical assisting, the ma to lpn bridge program online provides a seamless way to become a Licensed Practical Nurse. This pathway can lead to higher responsibility, pay, and further advancement.

If you’d like to pursue more advanced science studies, a bs in biology online offers a flexible option to earn your bachelor’s degree. These programs suit those aiming for research, laboratory, or further pre-medical preparation.

Interested in nursing? asn online nursing programs enable you to earn your associate’s degree and qualify for RN licensure, often while balancing work and other commitments.

Whether starting out or advancing your expertise, these online pathways make entering healthcare and scientific careers accessible and flexible for diverse learners.

Best Scientists Citing Peter G. Parsons

Trending Scientists

Recently Published Articles